FDA Inspection 1252090 — LGM Pharma Solutions, LLC.

LGM Pharma Solutions, LLC. — FEI 3017140511

The FDA completed an inspection of LGM Pharma Solutions, LLC. on August 6, 2025 in Rosenberg, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 6, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rosenberg, TX (United States)

Citations

IDCFRDescription
113621 CFR 211.25(c)Inadequate number of personnel
119421 CFR 211.42(c)Defined areas of adequate size for operations
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
356521 CFR 211.58Buildings not maintained in good state of repair